W. Wolfgang Fleischhacker, MD

Original Research

Quality of Life in Schizophrenia: The Impact of Psychopathology, Attitude Toward Medication, and Side Effects

July 1, 2004

Letter to the Editor

Transient Hyperproinsulinemia DuringTreatment With Clozapine and Amisulpride

June 1, 2004

Letter to the Editor

Improvement of Psychosis During Treatment With Estrogen and Progesterone in a Patient With Hypoestrogenemia

February 1, 2004

Original Research

Olanzapine Induces Insulin Resistance: Results From A Prospective Study

December 15, 2003

Academic Highlights

New Developments in Antipsychotic Therapy.

November 15, 2003

Article

Factors Influencing Compliance in Schizophrenia Patients

November 1, 2003

Original Research

Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic

October 15, 2003

Letter to the Editor

Worsening of Psychosis After Replacement of Adjunctive Valproate With Topiramate in a Schizophrenia Patient

October 15, 2003

Original Research

Attitudes of Patients With Schizophrenia Toward Placebo-Controlled Clinical Trials

March 15, 2003

Original Research

Attitudes Toward Antipsychotics Among Outpatient Clinic Attendees With Schizophrenia

January 1, 2002

Article

Introduction: Weight Gain: A Growing Problem in Schizophrenia Management

June 1, 2001

Article

The Clinical Implications of Weight Gain in Schizophrenia

June 1, 2001